Bristol-Myers pursues OTC sales for Pravachol
No surprise here. Statins have been OTC in Britain for the past year or so. Incidentally Pravachol is Bristol-Myers’ biggest seller, and its patent will be expiring soon. This is purely money-based – don’t believe anything about “health benefits” that the drug company claiming is behind the move.
ADVERTISEMENT
Get free updates delivered free to your inbox.
Search thousands of physician, PA, NP, and CRNA jobs now.
Comments are moderated before they are published. Please read the comment policy.
